Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection) VAUGHAN, Ontario and TAMPERE, Finland, Feb. 1, 2023 – Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Modulight Corporation (“Modulight”), a biomedical laser company, today announced that the U.S. Food and Drug Administration (FDA) has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT) for the treatment Continue reading →Modulight Investor Contacts: Ulla Haapanen ulla.haapanen@modulight.com (408) 218-7960 Modulight Media Contacts: Zoe Ylöniemi zoe.yloniemi@modulight.com (408) 239-3488 Bausch + Lomb Investor Contacts: Arthur Shannon/Allison Ryan arthur.shannon@bausch.com allison.ryan@bausch.com (877) 354-3705 (toll free); (908) 927-0735 Bausch + Lomb Media Contacts: Lainie Keller/Kristy Marks lainie.keller@bausch.com kristy.marks@bausch.com (908) 927-1198; (908) 927-0683 Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection) VAUGHAN, Ontario and TAMPERE, Finland, Feb. 1, 2023 – Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global Continue reading →

Palo Alto, California & Tampere FINLAND, 26th February 2021 – Modulight, Inc., a leading biomedical & semiconductor laser manufacturer, will release new product platforms at Photonics West 2021. There is increasing demand for higher brightness, higher efficiency and reliable components for fiber lasers in material processing. To address the demand Modulight, who has 20 years of experience with high power pump lasers, is releasing new 9xxnm high power diode laser platforms targeted especially for fiber laser pumping. New diode platforms are optimized for high brightness, high efficiency and lower operating voltage. Continue reading →

Palo Alto, California & Tampere FINLAND, 19th March 2020 – Modulight, Inc. Dear Friends of Modulight laser family,Palo Alto, California & Tampere FINLAND, 19th March 2020 – Modulight, Inc. Dear Friends of Modulight laser family, We hope you and your loved ones are staying healthy and safe, despite the dramatic, ongoing COVID-19 pandemic. Modulight is also affected by COVID-19, like many other companies, and in the following we would like to inform you about our status. Modulight operations Modulight laser fab can be operated almost in a vacuum for months despite what happens around us, with little or no external supplies. Our laser process recycles Continue reading →

Palo Alto, California & Tampere FINLAND, 10th September 2019 – Modulight, Inc., a leading biomedical & semiconductor laser manufacturer, announced today nomination of Mr. Seppo Orsila as President & Chief Executive Officer. Mr. Orsila’s nomination is effective immediately. Dr. Petteri Uusimaa will simultaneously move to new role as Vice President, Chief Technology Officer of Modulight, Inc. The changes in leadership are part of continuous development as company continues to progress at accelerating pace. Dr. Uusimaa and Mr. Orsila continue to lead the company jointly as business partners and the largest Continue reading →

Palo Alto, California & Tampere FINLAND, April 3, 2017 – Modulight, Inc., a leading biomedical laser manufacturer, announced nomination of Mr. Jyrki Liljeroos as a senior advisor to Board of Directors today. Mr. Liljeroos’s nomination is effective from 1st April, 2017. He will work with company’s board in all aspects of the business and bring his extensive experience to Modulight. Mr. Liljeroos has a wide experience on pharmaceutical and healthcare industries, and business strategy. He has been the CEO and Executive Chairman of Santen Finland for 20 years. Mr. Liljeroos has Continue reading →